Literature DB >> 31711103

Policy Recommendations for Pharmacy Benefit Managers to Stem the Escalating Costs of Prescription Drugs: A Position Paper From the American College of Physicians.

Hilary Daniel1, Sue S Bornstein2.   

Abstract

Recent discussions about the increasing prices of prescription drugs have focused on pharmacy benefit managers (PBMs), third-party intermediaries for various types of employers and government purchasers who negotiate drug prices in health plans and thus play a crucial role in determining the amount millions of Americans pay for medications. In this position paper, the American College of Physicians expands on its position paper from 2016 by offering additional recommendations to improve transparency in the PBM industry and highlighting the need for reliable, timely, and relevant information on prescription drug pricing for physicians and patients.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31711103     DOI: 10.7326/M19-0035

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  2 in total

Review 1.  Bending Versus Transforming the Drug Cost Curve: A Matter of Political Will.

Authors:  Ajay Major; Blase N Polite
Journal:  Cancer J       Date:  2020 Jul/Aug       Impact factor: 2.074

2.  Understanding patient and physician responses to various cost-sharing programs for prescription drugs in South Korea: A multilevel analysis.

Authors:  Kyung-Bok Son; Eui-Kyung Lee; Sang-Won Lee
Journal:  Front Public Health       Date:  2022-08-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.